MaxLinear, Inc. Form 10-Q Summary
Business Context and Reporting Period
MaxLinear is a fabless semiconductor company providing radio-frequency and mixed-signal integrated circuits for broadband communications, including cable modems, gateways, set-top boxes and digital televisions. This unaudited report covers the three and six months ended June 30, 2013, compared with the corresponding 2012 periods.
Key Financial Metrics
| Metric | Q2 2013 | Q2 2012 | Six Months 2013 | Six Months 2012 |
|---|---|---|---|---|
| Net revenue | $29.8 million | $24.4 million | $56.3 million | $45.1 million |
| Gross profit | $17.3 million | $15.1 million | $34.0 million | $27.5 million |
| Gross margin | 58% | 62% | 60% | 61% |
| Operating loss | $2.8 million | $2.5 million | $5.0 million | $9.0 million |
| Net loss | $2.9 million | $2.6 million | $5.2 million | $9.1 million |
| Net loss per share | $0.09 | $0.08 | $0.16 | $0.27 |
| Operating cash flow | Not separately provided | Not separately provided | $7.0 million | $(0.1) million |
Revenue was divided between cable products of $20.0 million in Q2 and $38.6 million for the six-month period, and terrestrial products of $9.8 million and $17.7 million, respectively. Research and development expense was $12.3 million in Q2 and $23.8 million year-to-date; selling, general and administrative expense was $7.8 million and $15.2 million, respectively. Stock-based compensation was $3.3 million in Q2 and $6.1 million year-to-date.
At June 30, 2013, cash and cash equivalents were $24.7 million, short- and long-term investments totaled $56.5 million, and total cash, cash equivalents and investments were $81.3 million. Working capital was $60.0 million. The filing indicates no material funded debt; interest expense was $4 thousand for the first six months, primarily related to capital leases and licensed technology. Total assets were $117.7 million and the accumulated deficit was $64.2 million.
Material Changes Versus Prior Comparable Period
- Q2 revenue increased 22%; six-month revenue increased 25%, driven primarily by cable products, including DOCSIS 3.0 cable modems and video server-gateway applications.
- Cable revenue increased 24% in Q2 and 38% year-to-date, while terrestrial revenue increased 17% in Q2 and 4% year-to-date.
- Gross margin declined to 58% in Q2 from 62% and to 60% year-to-date from 61%. The decline primarily reflected a $1.1 million impairment charge for production masks, partly offset by higher-margin 65-nanometer products and manufacturing-cost reductions.
- The operating loss improved year-to-date despite higher operating expenses, reflecting increased revenue and operating leverage. Q2 operating loss increased modestly year over year.
- Operating cash flow improved substantially to $7.0 million from an operating cash outflow of $0.1 million, aided by noncash stock compensation of $6.1 million and the production-mask impairment.
- Cash and investments increased to $81.3 million from $77.3 million at December 31, 2012, although short-term investments declined as more investments were classified as long-term.
- Accrued price protection liability increased to $10.7 million from $7.9 million at year-end, reflecting $9.9 million of charges against revenue and $7.1 million of payments during the six months.
Outlook, Risks, Contingencies and Unusual Items
Management expects cash and investments to fund projected operating requirements for at least the next twelve months, but states that additional capital or indebtedness may be required in the future. No specific revenue or earnings guidance is provided. Management expects research and development and selling, general and administrative expenses to increase as the company expands its product portfolio, sales organization and international infrastructure.
Key risks include customer concentration, distributor inventory and pricing adjustments, semiconductor-cycle volatility, rapid average selling price erosion, lengthy design-win and qualification cycles, reliance on third-party Asian foundries and assembly providers, and exposure to product obsolescence and inventory write-downs. Products shipped to Asia represented 93% of Q2 revenue and 92% of six-month revenue. One customer represented 23% of Q2 revenue and 26% of six-month revenue; the ten largest customers represented 73% of both periods.
Silicon Laboratories litigation remains material. Trial in the principal related actions is scheduled for February 11, 2014. MaxLinear has not accrued a loss contingency because it has not determined that an unfavorable outcome is probable or reasonably possible, nor that any loss range is reasonably estimable. The company also faces an IRS examination for 2010 and 2011; management does not expect unrecognized tax benefits to change significantly over the next twelve months.
The company issued approximately 0.8 million Class A shares in May 2013 to settle 2012 bonus awards, improving cash preservation but contributing to potential dilution. Management expects to implement a similar equity-based plan for 2013, with settlement at the compensation committee's discretion in cash, stock or a combination. Disclosure controls were assessed as effective, and no material change in internal control over financial reporting was identified.
Investor Verification Items
- Verify the sustainability of cable-driven revenue growth and the timing of terrestrial-market demand.
- Assess the effect of distributor pricing credits, stock rotation rights and the $10.7 million accrued price protection liability on future revenue and margins.
- Determine whether gross margins recover after the production-mask impairment and how product mix and average selling prices evolve.
- Monitor customer concentration, purchase-order cancellations and distributor inventory levels.
- Track cash consumption, future equity-based compensation, potential dilution and any need for additional financing.
- Follow the Silicon Laboratories patent litigation, including the February 2014 trial and possible injunction, damages or licensing exposure.
- Review the IRS examination and the company's continued valuation allowance on U.S. federal and California deferred tax assets.